Long term improvement in quality of life in Parkinson’s disease after deep brain stimulation of the subthalamic nucleus: an observational cohort
Clinical Parkinsonism & Related Disorders · 2026 · 15 · 100481
DOI: 10.1016/j.prdoa.2026.100481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Parkinsonism & Related Disorders, 2026. Verfasst von Ka Loong Kelvin Au und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Kansas Medical Center, Department of Neurology, USA. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Long-term quality of life (QoL) outcomes following subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease (PD) remain incompletely characterized beyond 10-15 years.
Objective
To evaluate long term QoL and clinical outcomes in PD patients undergoing bilateral STN-DBS with follow up extending up to 25 years.
Methods
Single center, prospective observational cohort study at a tertiary academic medical center. A total of 387 PD patients who underwent bilateral STN DBS were followed longitudinally with annual assessments for up to 25 years. Annual assessments included PDQ-39, Unified Parkinson's Disease Rating Scale (UPDRS), Levodopa equivalent daily dose (LED), Geriatric Depression Scale (GDS), Montreal Cognitive Assessment (MoCA) and Epworth Sleepiness Scale (ESS).
Results
Among 387 patients (baseline PDQ-39, 35.34 ± 14.79), QoL improved significantly at year 1 (24.38 ± 14.39; p < 0.001) and year 3 (29.84 ± 15.70; p < 0.001), followed by stabilization at or near baseline through 25 years without sustained worsening. Motor function (UPDRS Part III, OFF state) improved significantly through year 12 (p < 0.001), with sustained reductions in OFF time and dyskinesia through year 20 (p < 0.001). LED was reduced by approximately 50% and remained significantly lower through year 19 (p < 0.001). Cognitive scores declined over time, with significant worsening beginning at year 2 (p < 0.03), and depression scores worsened gradually after year 3 (p = 0.04). Sleepiness improved transiently through year 7 (p = 0.02) before returning to baseline. PDQ-39 subscores showed domain-specific patterns, with sustained worsening observed in communication.
Conclusion
Bilateral STN DBS is associated with significant early improvements in QoL followed by long-term stabilization without deterioration below baseline for up to 25 years. These findings suggest that STN DBS provides durable symptomatic benefit and relative preservation of QoL compared with the expected progressive decline in PD. Long-term management should prioritize non-motor symptoms, particularly cognition and communication.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Kansas Medical Center, Department of Neurology, USA.
Zitieren
APA
Au, K. L. K., Pahwa, V., Lyons, K. E., & Pahwa, R. (2026). Long term improvement in quality of life in Parkinson’s disease after deep brain stimulation of the subthalamic nucleus: an observational cohort. Clinical Parkinsonism & Related Disorders, 15, 100481. https://doi.org/10.1016/j.prdoa.2026.100481
Vancouver
Au KLK, Pahwa V, Lyons KE, Pahwa R. Long term improvement in quality of life in Parkinson’s disease after deep brain stimulation of the subthalamic nucleus: an observational cohort. Clinical Parkinsonism & Related Disorders. 2026;15:100481. doi:10.1016/j.prdoa.2026.100481
BibTeX
@article{Au2026,
author = {Au, Ka Loong Kelvin and Pahwa, Vinay and Lyons, Kelly E and Pahwa, Rajesh},
title = {Long term improvement in quality of life in Parkinson’s disease after deep brain stimulation of the subthalamic nucleus: an observational cohort},
journal = {Clinical Parkinsonism & Related Disorders},
year = {2026},
volume = {15},
pages = {100481},
doi = {10.1016/j.prdoa.2026.100481}
}
EUVIMED